{"authors": [["Semenova", "A E", "AE", "National Medical Research Center for Cardiology."], ["Sergienko", "I V", "IV", "National Medical Research Center for Cardiology."]], "text": "The prevalence of multicomponent therapy in treatment of cardiovascular diseases makes fixed combinations of drugs very useful. The fixed combination of rosuvastatin with ACE inhibitor lisinopril and calcium antagonist amlodipine allows to control effectively two main cardiovascular risk factors: hypercholesterolemia and arterial hypertension. The efficacy of each of the components and their combined administration in primary and secondary prevention of cardiovascular disease has been demonstrated in clinical studies. The convenience of several drugs combination in a single tablet increases adherence to therapy facilitating regular intake of all treatment components and reliably reducing the risk of cardiovascular complications.", "id": "29276932", "date": null, "title": "[Lisinopril, Amlodipine, Rosuvastatin as a Novel Fixed Combination in the Fight Against Cardiovascular Disease].", "doi": null, "journal": ["Kardiologiia", "Kardiologiia"]}